Buggy Y - Search Results

1

Expression of ADAM-9 mRNA and protein in human breast cancer.

O'Shea C, McKie N, Buggy Y, Duggan C, Hill AD, McDermott E, O'Higgins N, Duffy MJ. O'Shea C, et al. Among authors: buggy y. Int J Cancer. 2003 Jul 20;105(6):754-61. doi: 10.1002/ijc.11161. Int J Cancer. 2003. PMID: 12767059 Free article.

2

Overexpression of the Ets-1 transcription factor in human breast cancer.

Buggy Y, Maguire TM, McGreal G, McDermott E, Hill AD, O'Higgins N, Duffy MJ. Buggy Y, et al. Br J Cancer. 2004 Oct 4;91(7):1308-15. doi: 10.1038/sj.bjc.6602128. Br J Cancer. 2004. PMID: 15365563 Free PMC article.

3

Ets2 transcription factor in normal and neoplastic human breast tissue.

Buggy Y, Maguire TM, McDermott E, Hill AD, O'Higgins N, Duffy MJ. Buggy Y, et al. Eur J Cancer. 2006 Mar;42(4):485-91. doi: 10.1016/j.ejca.2005.10.018. Epub 2005 Dec 27. Eur J Cancer. 2006. PMID: 16380248

4

Associations and interactions between Ets-1 and Ets-2 and coregulatory proteins, SRC-1, AIB1, and NCoR in breast cancer.

Myers E, Hill AD, Kelly G, McDermott EW, O'Higgins NJ, Buggy Y, Young LS. Myers E, et al. Among authors: buggy y. Clin Cancer Res. 2005 Mar 15;11(6):2111-22. doi: 10.1158/1078-0432.CCR-04-1192. Clin Cancer Res. 2005. PMID: 15788656

5

Expression of the breast cancer metastasis suppressor gene, BRMS1, in human breast carcinoma: lack of correlation with metastasis to axillary lymph nodes.

Kelly LM, Buggy Y, Hill A, O'Donovan N, Duggan C, McDermott EW, O'Higgins NJ, Young L, Duffy MJ. Kelly LM, et al. Among authors: buggy y. Tumour Biol. 2005 Jul-Aug;26(4):213-6. doi: 10.1159/000086955. Epub 2005 Jul 6. Tumour Biol. 2005. PMID: 16006775

6

Tamoxifen-induced ER-alpha-SRC-3 interaction in HER2 positive human breast cancer; a possible mechanism for ER isoform specific recurrence.

Mc Ilroy M, Fleming FJ, Buggy Y, Hill AD, Young LS. Mc Ilroy M, et al. Among authors: buggy y. Endocr Relat Cancer. 2006 Dec;13(4):1135-45. doi: 10.1677/erc.1.01222. Endocr Relat Cancer. 2006. PMID: 17158759

7

STAT4 expression and activation is increased during mitosis in vitro and in vivo in skin- and mucosa-derived cell types: implications in neoplastic and inflammatory skin diseases.

Ferreli C, Lai C, August S, Buggy Y, Kumar P, Brownlow N, Parker P, Friedmann PS, Ardern-Jones M, Pickard C, Healy E. Ferreli C, et al. Among authors: buggy y. J Eur Acad Dermatol Venereol. 2017 Oct;31(10):1663-1673. doi: 10.1111/jdv.14342. Epub 2017 Aug 10. J Eur Acad Dermatol Venereol. 2017. PMID: 28516569

8

Neuropsychiatric events with varenicline: a modified prescription-event monitoring study in general practice in England.

Buggy Y, Cornelius V, Fogg C, Kasliwal R, Layton D, Shakir SA. Buggy Y, et al. Drug Saf. 2013 Jul;36(7):521-31. doi: 10.1007/s40264-013-0046-6. Drug Saf. 2013. PMID: 23657823

9

Reasons for and time to discontinuation of rimonabant therapy: a modified prescription-event monitoring study.

Willemen MJ, Mantel-Teeuwisse AK, Buggy Y, Layton D, Straus SM, Leufkens HG, Egberts TC. Willemen MJ, et al. Among authors: buggy y. Drug Saf. 2012 Dec 1;35(12):1147-58. doi: 10.1007/BF03262000. Drug Saf. 2012. PMID: 23061737

10

Risk of depressive episodes with rimonabant: a before and after modified prescription event monitoring study conducted in England.

Buggy Y, Cornelius V, Wilton L, Shakir SA. Buggy Y, et al. Drug Saf. 2011 Jun 1;34(6):501-9. doi: 10.2165/11588510-000000000-00000. Drug Saf. 2011. PMID: 21585222

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12 results

Search Page